MedPath

Heart Failure Ventricular Pressure Time Profile

Completed
Conditions
Heart Failure
Interventions
Other: Echocardiography
Other: NTproBNP
Other: Arterial tonometry
Registration Number
NCT02791074
Lead Sponsor
National Heart Centre Singapore
Brief Summary

This proposed study aim to:

1. Determine intra-LV pressure-time profile non-invasively using recently developed echo Doppler VFM analysis and applanation tonometry and myocardial elastic properties, in HF subjects (both HFNEF and HFREF) compared to normal volunteers.

2. Correlate calculated intra-LV pressure parameters with NT ProBNP levels.

Detailed Description

Heart failure (HF) is a common disease and its syndrome is difficult to diagnose. HF with reduced ejection fraction (HFREF) may be diagnosed based on impaired LVEF (\<50%). However, diagnosis of HF with normal ejection fraction (HFNEF) is mainly based on the presence of signs and symptoms.

Central to diagnosis of HF is estimation of intra-cardiac pressure, which can only be obtained from invasive catheterization.

This proposed study aim to:

1. Determine intra-LV pressure-time profile non-invasively using recently developed echo Doppler VFM analysis and applanation tonometry and myocardial elastic properties, in HF subjects (both HFNEF and HFREF) compared to normal volunteers.

2. Correlate calculated intra-LV pressure parameters with NT ProBNP levels.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
75
Inclusion Criteria
  • Either

    1. has presented to hospital with a primary diagnosis of Heart Failure or

    2. is attending a hospital clinic for management of Heart Failure within 6 months of an episode of decompensated heart failure, which either:

      • resulted in a hospital admission (primary diagnosis) or
      • was treated in out-patient clinic
  • LVEF >50% is used as cut-off value for HFNEF and LVEF < 50% for HFREF.

  • NT-proBNP within 7 days of admission > 220pg/ml. If there is no result available, NT-proBNP on the same day as echo scan must be > 220pg/ml.

Exclusion Criteria
  • Haemodynamically significant valve disease defined as more than mild degree of valve stenosis, or more than moderate degrees of mitral or aortic valve regurgitation.
  • History of valvular disease, i.e. rheumatic heart disease and/or having undergone valvular replacement.
  • Isolated right heart failure due to pulmonary disease.
  • Presence of haemodynamically significant obstructive lesions of left ventricular outflow tract.
  • History of any organ transplant or who was on a transplant list (life expectancy < 6 months at time of enrollment).
  • Presence of end-stage renal failure.
  • Pregnancy.
  • The patient is unable to provide written informed consent.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
ControlArterial tonometryHealthy Volunteers will undergo the following studying procedures: Echocardiography Arterial tonometry
Heart Failure PatientsArterial tonometryPatients will undergo the following studying procedures: NTproBNP Echocardiography Arterial tonometry
ControlEchocardiographyHealthy Volunteers will undergo the following studying procedures: Echocardiography Arterial tonometry
Heart Failure PatientsNTproBNPPatients will undergo the following studying procedures: NTproBNP Echocardiography Arterial tonometry
Heart Failure PatientsEchocardiographyPatients will undergo the following studying procedures: NTproBNP Echocardiography Arterial tonometry
Primary Outcome Measures
NameTimeMethod
First occurrence of cardiovascular event1 Year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

National Heart Centre Singapore

🇸🇬

Singapore, Singapore

© Copyright 2025. All Rights Reserved by MedPath